Upadacitinib for Immune Checkpoint Inhibitor–Related Dermatitis: A Nonrandomized Clinical Trial - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluation of Upadacitinib for Dermatitis Associated with Immune Checkpoint Inhibitors: Findings from a Nonrandomized Clinical Study

  • By

  • Chengshui Chen

  • Xinyu Liang

  • Zheng Peng

  • Yan Zou

  • Huijuan He

  • Xiaoyan Zhang

  • Yi He

  • Shixiu Wu

  • May 1, 2026

Share

Original Source(s)

Related Content